Core Viewpoint - The article emphasizes the need to explore non-invasive brain-computer interface (BCI) technologies rather than invasive methods, as proposed by Chinese Academy of Sciences academician Zheng Hairong [2][3][9]. Industry Overview - The global BCI market is projected to grow from $2.35 billion in 2023 to $10.89 billion by 2033, indicating significant investment and interest in this sector [5]. - Major players in the BCI field include Neuralink, which focuses on invasive methods, and Synchron, which has developed a less invasive approach with support from tech giants like Apple and NVIDIA [2][7]. Technological Developments - Neuralink has reported advancements in its invasive BCI technology, with patients able to control complex devices using their thoughts, showcasing a leap from simple cursor control to intricate robotic manipulation [5][6]. - Synchron has achieved key safety milestones with its BCI devices, including FDA approval for temporary implants and successful long-term trials without severe adverse events [8]. Critique of Current Approaches - Zheng Hairong criticizes the invasive methods as "brute force engineering," arguing that they fail to understand the complexity of the human brain and its evolutionary history [3][9]. - He highlights the challenges of biological compatibility in invasive BCIs, noting that many electrodes fail due to the brain's natural resistance [6]. Alternative Approaches - Zheng advocates for a non-invasive approach that utilizes external technologies like ultrasound and fMRI to read and potentially write brain signals without penetrating the skull [9][10]. - This method aims to decode brain activity by observing the relationship between blood flow and neural activity, likening it to a soldier and their supplies [10]. Future of AI and BCI - Zheng outlines a three-stage evolution of AI, with the final stage being "biological intelligence" achieved through effective BCI integration [12][13]. - He envisions a future where hospitals transform into AI-driven data centers, moving away from traditional medical practices [14]. Ethical Considerations - The article raises concerns about the ethical implications of BCI technology, emphasizing the need for strong regulations to prevent misuse and ensure human control over technology [14][15]. - Global legislative efforts are underway to protect brain data, indicating a growing recognition of the ethical challenges posed by BCI advancements [15]. Timeline for Adoption - Zheng estimates that it may take 20 to 30 years for BCI technology to become a part of everyday life for the general public [17].

Core Viewpoint - The global brain-computer interface (BCI) sector is experiencing significant advancements, with companies like Neuralink and Synchron leading the way in different technological approaches [2][4][6] Group 1: Company Developments - Neuralink has increased its number of human trial participants to 7 and demonstrated the ability to control a robotic arm using thoughts [2] - Synchron has achieved native integration with Apple devices through a new protocol, enhancing its market presence [2] - Precision Neuroscience received FDA approval for a temporary implantable device, marking a step towards commercialization [6] Group 2: Market Growth - The global BCI market is projected to grow from $2.35 billion in 2023 to $10.89 billion by 2033, indicating a substantial increase in investment and interest [4] Group 3: Technological Approaches - Two main technological paths are identified: invasive methods like those used by Neuralink, which require surgical implantation, and less invasive methods like those of Synchron, which utilize blood vessels for sensor delivery [2][6] - The invasive approach has shown promising results, allowing patients to perform complex tasks, but faces challenges related to biological compatibility [5][6] Group 4: Alternative Perspectives - Chinese Academy of Sciences academician Zheng Hairong advocates for non-invasive BCI technologies, arguing that current invasive methods are outdated and lack imagination [3][8] - Zheng proposes using external physical methods like ultrasound and fMRI to read and potentially write brain information without surgical intervention [8][9] Group 5: Future Implications - Zheng predicts that the future of AI will involve a three-stage evolution, culminating in "biological intelligence" achieved through effective brain-computer integration [10][11] - He envisions a healthcare system transformed by AI, moving away from traditional methods to a data-centric model that predicts and manages diseases [12] Group 6: Ethical Considerations - The ethical implications of BCI technology are becoming a global concern, with countries like Chile and Colorado taking legislative steps to protect brain data [13] - Zheng emphasizes the need for strong regulations to ensure that brain-computer interfaces remain under human control, highlighting the potential risks of losing that control [12][13] Group 7: Timeline for Adoption - Zheng estimates that it may take 20 to 30 years for BCI technology to become a part of everyday life for the general public [14]

Group 1 - Brain-computer interface (BCI) technology is expected to lead a new revolution in medical care, particularly in rehabilitation, addressing significant medical needs in the future [1] - Current research focuses on understanding brain functions and mechanisms related to diseases, with potential applications for stroke patients and the visually impaired [1][2] - The next generation of BCI breakthroughs will depend on advancements in new electrode materials, precise decoding of complex neural information, and efficient non-invasive neural modulation techniques [1][2] Group 2 - Multiple research teams in China have announced that BCI technology has entered clinical stages, showing promise in helping patients regain motor functions [2] - Despite progress, significant technical challenges remain in translating BCI technology into safe and effective clinical solutions, requiring rigorous clinical validation [2] - Neuralink, founded by Elon Musk, is a leading company in invasive BCI clinical advancements, achieving notable tasks with spinal cord injury patients, but faces challenges related to biocompatibility and electrode lifespan [2] Group 3 - The development of non-invasive BCI technology, which interprets and translates neural signals without surgery, is a key research direction due to the complexity of brain cell functions [2] - BCI tools are anticipated to significantly enhance disease diagnosis and treatment, necessitating a re-evaluation of disease causes and therapies [3] - The evolution of AI is seen as progressing from data intelligence to physical intelligence and ultimately to biological intelligence through BCI, enabling deep integration of human-machine intelligence [3][6] Group 4 - Biological intelligence and BCI technology are viewed as core breakthroughs in artificial intelligence, expected to reshape future industrial forms, scientific paradigms, and social structures [6]

Investment Rating - The industry investment rating is "Overweight" indicating that the industry index is expected to outperform the benchmark by more than 5% in the next six months [23]. Core Insights - The brain-computer interface (BCI) sector is experiencing accelerated development, with the global market projected to reach approximately $7 billion by 2030, growing at a CAGR of 16.4% from 2025 to 2030 [1][7]. - The domestic BCI market is gaining significance, with its market size reaching 1.73 billion yuan in 2023, an increase of over 5 percentage points compared to 2020 [1][10]. - China has a first-mover advantage in the non-invasive BCI route, while also making strides in invasive technologies, evidenced by recent clinical trial breakthroughs [2][3]. Summary by Sections Market Growth and Trends - The global BCI market is on a growth trajectory, with significant increases in investment and financing in the past two years [1][14]. - The domestic market's share has been increasing, with a notable rise in the number of investment events and financing amounts in the BCI sector [16][14]. Technological Developments - Non-invasive BCI technologies are more fragmented, focusing on commercializing applications in vertical fields, while invasive technologies face higher technical barriers [2][3]. - Recent advancements include the development of the world's first "dual-loop" BCI system by Tianjin University and Tsinghua University, and successful clinical trials for invasive BCIs in China [2][3]. Government Policies and Support - The Chinese government is actively promoting the standardization and ethical guidelines for BCI research and applications, with several policies introduced to support the industry [3][17]. - Local governments, particularly in Beijing and Shanghai, are accelerating the development of BCI industries through specific action plans and funding initiatives [3][17]. Industry Chain and Key Players - The BCI industry chain includes upstream hardware suppliers, midstream product providers, and downstream applications in healthcare, smart living, and military sectors [4][18]. - Key companies in the BCI sector include Qi Sheng Technology, DiNaiKe, and others, with varying market capitalizations [19].

脑机接口板块延续活跃，际华集团（601718）3连板，翔宇医疗、创新医疗（002173）涨超7%，乐普医 疗（300003）、荣泰健康（603579）跟涨。 暗盘资金正涌入这些股票，点击速看>>> ...

Core Insights - Neuralink has achieved a significant milestone with the ability to implant electrodes in the brain at a speed of 1.5 seconds per electrode, showcasing advancements in brain-machine interface (BMI) technology [26][66]. - The company has outlined an ambitious three-year roadmap aiming to restore vision to the blind by 2026 and integrate human consciousness with AI by 2028 [26][64]. - Seven volunteers have successfully used the Neuralink device to control games and robotic arms through thought, demonstrating the practical applications of this technology [28][34]. Group 1: Shenzhen's Breakthrough in Brain-Machine Interface - Shenzhen Second People's Hospital has successfully completed the first real-time decoding surgery in South China using high-density flexible film electrodes, marking a significant advancement in BMI technology [2][5]. - The surgery involved a 40-year-old patient with a brain vascular malformation, utilizing a 128-channel flexible electrode to achieve 97% accuracy in motion intention decoding with a 60-millisecond latency [2][10]. - This achievement represents a full cycle of "research-manufacturing-clinical validation" in Shenzhen's BMI technology, showcasing local innovation and collaboration [5][20]. Group 2: Clinical Application and Innovation - The high-density film electrodes developed by a local company, MicroLing Medical, are only 0.01 mm thick and provide excellent flexibility and biocompatibility, significantly improving signal acquisition quality [2][12]. - The establishment of the "Brain-Machine Interface Clinical Evaluation and Transformation Center" at Shenzhen Second People's Hospital aims to accelerate the clinical application of BMI technology, integrating research and clinical practice [22][24]. - The center will focus on standardizing data collection and management throughout the entire process from pre-operative assessment to post-operative rehabilitation, creating a closed-loop transformation path [24][22]. Group 3: Future Directions and Industry Impact - The successful application of BMI technology in Shenzhen is expected to serve as a model for the integration of medical and engineering resources, promoting innovation in treating neurological diseases [18][19]. - The collaboration between Shenzhen Second People's Hospital and MicroLing Medical exemplifies the synergy between academia, industry, and healthcare, aiming to enhance the clinical translation of advanced technologies [4][16]. - The advancements in BMI technology not only promise to improve patient outcomes but also position Shenzhen as a leader in the global neurotechnology landscape [20][19].

Core Insights - The brain-computer interface (BCI) sector is experiencing significant advancements, with both domestic and international developments highlighting its potential [1][2][3] Industry Development - The BCI technology is a crucial intersection of neuroscience and brain-like computing, categorized into invasive, semi-invasive, and non-invasive types based on signal acquisition and output methods [2] - The market size for BCIs in China is projected to reach 3.2 billion yuan in 2024, exceeding 5.5 billion yuan by 2027; globally, the medical application market for BCIs is expected to reach between 40 billion to 145 billion USD from 2030 to 2040 [2] - Various local governments in China are actively promoting BCI industry development, with plans to establish a robust ecosystem by 2030, including breakthroughs in foundational research and technology [2][3] Company Initiatives - Companies in China are leading in the development of intelligent BCI systems, with "Beijing Brain No. 1" and "Beijing Brain No. 2" systems currently in clinical validation stages [4] - Sanbo Brain Hospital recently completed a successful trial using an invasive BCI to assist a hemiplegic patient in regaining motor function [4] - Chengyi Tong is focusing on non-invasive BCI technologies while also preparing for potential invasive applications [4] - Entropy Technology has launched a non-invasive BCI product aimed at enhancing focus among youth, utilizing scalp electrodes and flexible sensors [4]

Market Overview - The Hong Kong stock market is experiencing a decline, with the Hang Seng Index dropping by 0.87% as large funds adjust their positions, particularly in the financial sector [1] - In contrast, the A-share market is witnessing a collective rise, attributed to the China Securities Regulatory Commission's new logo, interpreted by investors as a sign of a "triple win" for the stock market, listed companies, and investors [1] Trade Relations and Tariffs - Concerns over tariffs remain prevalent in the Hong Kong market, with the U.S. government indicating that trade negotiations may extend beyond the initial deadline set by the Trump administration [2] - The U.S. Treasury Secretary stated that negotiations with multiple trade partners could continue until September, reflecting a lack of significant progress in talks with major partners [2] - China's firm stance against sacrificing its interests in trade negotiations has influenced other countries, such as India, to adopt a tougher approach [2] Inflation and Economic Indicators - The U.S. core PCE price index for May increased by 2.68% year-on-year, surpassing expectations and reaching its highest level since February 2025 [3] - The inflation outlook suggests that the Federal Reserve is unlikely to lower interest rates in the upcoming meetings, with expectations of inflation peaking in July or August [3] - In China, industrial profits for large enterprises declined by 1.1% year-on-year from January to May, with a significant drop of 9.1% in May alone [3] Legislative Developments - The U.S. Senate passed the "Big Beautiful Bill" with a narrow margin, which could lead to increased government debt to stimulate economic growth [4] - The bill's passage may have mixed implications, as the U.S. national debt exceeds $36 trillion, raising concerns about sustainability [4] - The bill includes compromises that may benefit sectors such as healthcare and renewable energy, positively impacting related stocks [4] Stock Performance and New Listings - Newly listed stocks like Chow Tai Fook (06168) have seen significant gains, with a 25% increase on the day, nearly doubling in value over three days [5] - Old Town Gold (06181) also benefited from the strong performance of its new Singapore store, with a nearly 15% rise in stock price [5] - Cloud Wisdom (09678), the first AGI stock in Hong Kong, surged over 44% on its debut, driven by strong revenue growth projections [6] Sector Focus - The military industry is gaining attention due to reports of Iran negotiating the purchase of Chinese fighter jets and abandoning U.S. GPS in favor of China's BeiDou navigation system [8] - The photovoltaic glass sector is addressing supply-demand imbalances, with plans for a 30% production cut starting in July to stabilize prices [9] - Companies like Eastman Chemical (00189) are expected to benefit from increased demand for refrigerants, with a significant rise in profitability anticipated [10][11]

脑机接口行业点评 Neuralink 发布会公布三年计划，关注脑机接口进展 2025 年 06 月 30 日 ➢ 完成 E 轮融资加快研发，Neuralink 公布未来三年的发展计划。今年 6 月 上旬，Neuralink 宣布完成 6.5 亿美元的 E 轮融资，主要投资者包括方舟投资、 德丰杰成长基金、创始人基金、光速创投、红杉资本、兴盛资本等。发布会上 Neuralink 公布了未来的三年计划——2025 年第四季度：在言语皮层植入设备， 直接从大脑信号中解码有意识的词语，转换为语音。2026 年：将电极数量增加 到 3000 个，让首位「盲视」参与者重获视觉，初期是低分辨率导航，最终达到 超人多波段视觉。2027 年：增加通道数量至 10000 个，首次实现多设备植入 （运动皮层、言语皮层或视觉皮层）。2028 年：每个植入物达到超过 25000 个 通道，拥有多个植入物，能访问大脑的任何部分，治疗精神疾病、疼痛、失调， 并且与 AI 集成。马斯克宣称要在 2028 年实现将人类大脑与 AI 全面集成，实现 意识层面的互联。 ➢ 事件：6 月 28 日，马斯克召开 Neuralink 线上发布会，公布脑 ...

Core Insights - Neuralink is making steady progress in the brain-computer interface (BCI) sector, with its plans aligning with current industry trends and expectations [1][4] - The company aims to create a universal human brain input/output interface, with a long-term goal of achieving unprecedented bandwidth in neural activity communication [3][4] Group 1: Technological Developments - Neuralink has demonstrated that implanted devices allow users to control computers, play games, and operate robotic arms using brain signals [3] - The company plans to decode "intent language" directly from the speech cortex by the end of 2025 and expand the number of electrode channels to 3,000 by 2026 [4] - By 2028, Neuralink aims to increase the number of electrodes to 25,000, enabling comprehensive access to different brain regions for treating mental illnesses and exploring AI integration [4] Group 2: Industry Context - A technology expert from a Chinese BCI company noted that Neuralink's advancements and plans are valuable references for the industry, particularly in areas like motor function replacement and sensory restoration [4][5] - The expert emphasized that while the long-term goals of their company align with Neuralink's, their implementation strategies will be tailored to meet the specific needs of Chinese patients and market characteristics [5]